Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Aeye Health
AddedFeb 17, 2024
UpdatedJun 18, 2026
Aeye Health

Aeye Health

Seed

AEYE Health: An FDA-approved digital health startup using AI for autonomous interpretation of fundus images.

HQ
New York City, NY, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to revolutionize eye care through advanced technology, AEYE Health is an FDA-approved digital health startup specializing in AI-driven diagnostics. The company focuses on developing algorithms that provide immediate, autonomous interpretation of fundus images, targeting conditions such as diabetic retinopathy. Their innovative solutions are designed for use with both handheld and desktop retinal cameras, making high-quality eye care more accessible and efficient.

AEYE Health has garnered significant attention and investment from notable venture capital firms. The company's flagship product, AEYE-DS, is the first FDA-cleared AI technology capable of autonomously diagnosing diabetic retinopathy using portable retinal cameras. This groundbreaking achievement highlights their commitment to accuracy and accessibility, as evidenced by their clinical trial results showing 91% specificity and 93% sensitivity. AEYE Health's impact is profound, setting new standards in digital health and AI diagnostics.

Aeye Health - Similar Companies

Retina-Ai Health logo

Retina-Ai Health

Eyenuk logo

Eyenuk

eyenuk.com

Altris.AI logo

Altris.AI

altris.ai

Ocular Diagnostics logo

Ocular Diagnostics

Digital Diagnostics logo

Digital Diagnostics

Ai-Ris logo

Ai-Ris

oculolabs.org

Vitazi.ai logo

Vitazi.ai

vitazi.ai

Optain logo

Optain

optainhealth.com

Insight Optics logo

Insight Optics

io.care

Intelligent Retinal Imaging Systems logo

Intelligent Retinal Imaging Systems

Ainnova Tech logo

Ainnova Tech

ainnovatech.com

Eyebot logo

Eyebot

eyebot.tech

EyeTech Digital Systems logo

EyeTech Digital Systems

eyetechds.com

AmplifAI Health logo

AmplifAI Health

Tesseract Health logo

Tesseract Health

Aeye Health - Quick Facts

Who are Aeye Health's competitors?

Companies similar to Aeye Health include Retina-Ai Health, Eyenuk, Altris.AI and Ocular Diagnostics.

When was Aeye Health founded?

Aeye Health was founded in 2018.

Where is Aeye Health's headquarters located?

Aeye Health's headquarters is located in New York City, NY, US.

When was Aeye Health's last funding round?

Aeye Health's most recent funding round was for $10M (USD) in January 2022.

How much has Aeye Health raised to-date?

As of Jan 1, 2022, Aeye Health has raised a total of $10M (USD).

How many employees does Aeye Health have?

Aeye Health has 20 employees as of Feb 4, 2024.

Aeye Health - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Americas
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • AI Diagnostics
Tags
  • AI Operations
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software